Therefore, the above data suggested that Nrf2 overexpression reduced the killing effect of chemotherapeutic drug Ara-C on leukemia cells while inhibited the expression of RFC4, which might be the underlying cause of genetic unstable chemotherapeutic resistance in vivo. Here, NFE2L2 is linked to leukemia.